Sg Americas Securities, LLC Oncocyte Corp Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$1.15 - $2.25 $12,142 - $23,757	-10,559 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$2.04 - $3.59 $28,394 - $49,969	-13,919 Reduced 56.86%	10,559 $23,000
Q3 2021 Nov 01, 2021	BUY	$3.53 - $5.89 $86,407 - $144,175	24,478 New	24,478 $87,000
Q2 2021 Aug 12, 2021	SELL	$3.77 - $6.0 $45,262 - $72,036	-12,006 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.39 - $6.5 $28,694 - $78,039	12,006 New	12,006 $62,000
Q3 2020 Nov 09, 2020	SELL	$1.2 - $1.89 $28,246 - $44,488	-23,539 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$1.91 - $3.45 $44,959 - $81,209	23,539 New	23,539 $45,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $294M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.